SymBiosis Capital Partners, LLC
BENTONVILLE, AR · CIK 2006045 · 13F filing filed 2026-05-12
No investment adviser registration (Form ADV) found for this filer. It may be a parent company whose subsidiaries are the registered advisers, a bank or insurer, or a manager based outside the US.
$52.8m
reported value
-51.8% vs Q4 2025
6positions
100.0%in top 10
1 new
0 added
3 reduced
6 sold out
vs Q4 2025
Holdings, Q1 2026
The small lines show how much was held over the last 4 quarters (adjusted for stock splits).
| Security | Value | Change |
|---|---|---|
| EVOMMUNE INC EVMN | $29.4m55.80% | Unchanged |
| INVENTIVA SA IVA | $13.1m24.76% | Reduced -246.0k |
| WAVE LIFE SCIENCES LTD 96663EUR | $5.4m10.30% | New |
| RANI THERAPEUTICS HLDGS INC RANI | $2.7m5.11% | Reduced -2.6m |
| CLENE INC CLNN | $2.1m4.03% | Reduced -339.4k |
| SURROZEN INC *W EXP 08/01/203 | $2.4k0.00% | Unchanged |
Sold out since Q4 2025
| Security | Value then |
|---|---|
| VERASTEM INC VSTM | $15.4m2.0m shares |
| AMPLITECH GROUP INC AMPG | $13.2m2.6m shares |
| PRECIGEN INC PGEN | $12.5m3.0m shares |
| NUVATION BIO INC NUVB | $11.2m1.2m shares |
| AARDVARK THERAPEUTICS INC AARD | $6.3m476.6k shares |
| GENERATION BIO CO | $3.8m665.0k shares |
Stakes above 5%
Companies where this manager has reported owning more than 5% of a class of shares, on Schedule 13D (may seek influence) or 13G (passive): its latest filing for each, from 19 Dec 2024 on.
| Company | Stake |
|---|---|
| GENERATION BIO CO 13G · filed 2025-11-14 | 6.3% |